Skip to main content
SpringerLink
Log in

Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension

  • Published:
Advances in Therapy Aims and scope Submit manuscript

An Erratum to this article was published on 01 March 2008

Abstract

Arterial hypertension is a significant cause of end-stage renal failure; effective treatment of hypertensive patients reduces the rate of progression of this disorder. β-Blockers, particularly nonselective agents, are associated with deterioration of renal function in patients with chronic renal failure. Previous studies on the interaction of the β1-selective adrenergic antagonist bisoprolol with kidney function have been performed only acutely and over the short term. This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension. After a 2-wk run-in period on placebo, 87 consecutive hypertensive patients (46 men, 41 women) according to ESH-ESC (European Society of Hypertension/European Society of Cardiology) guidelines, aged from 27 to 64 y (mean age, 50±11 y), without renal or cardiovascular disease, were enrolled and assigned to treatment with bisoprolol 5 mg once daily for 6 mo. At recruitment and at 6 mo after treatment, renal function was assessed and renal hemodynamics evaluated in all patients through radioisotope studies. The mediumterm effects of bisoprolol included a significant reduction in blood pressure and heart rate (P< .001) without significant adverse drug reactions. Moreover, bisoprolol produced no alteration in renal function or hemodynamics, or in cardiac output. Data presented here indicate that bisoprolol 5 mg given once daily to treat patients with mild to moderate essential hypertension is effective and safe for treatment and for preservation of renal performance when given on a medium-term basis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age.Kidney Int. 1984;26:861–868.

    Article  CAS  PubMed  Google Scholar 

  2. London GM, Safar ME, Sassard JE, Levenson JA, Simon AC. Renal and systemic haemodynamics in sustained essential hypertension.Hypertension. 1984;6:743–754.

    CAS  PubMed  Google Scholar 

  3. Marin R, Gorostidi M, Fernandez-Vega F, Alvarez-Navascues R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.Kidney Int Suppl. 2005;99:S52-S56.

    Article  PubMed  Google Scholar 

  4. Brenner BM. Nephron adaptation to renal injury or ablation.Am J Physiol. 1985;249:F324-F327.

    CAS  PubMed  Google Scholar 

  5. Dworkin LD, Feiner HD, Randazzo J. Glomerular injury in uninephrectomized spontaneously hypertensive rats: a consequence of glomerular capillary hypertension.J Clin Invest. 1986;77: 797–809.

    Article  CAS  PubMed  Google Scholar 

  6. Ljungman S, Wikstrand J, Hartford M, Aurell M, Lindstedt G, Berglund G. Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension.Am J Hypertens. 1993;6:554–563.

    CAS  PubMed  Google Scholar 

  7. Cruickshank JM. Are we understanding beta-blockers?Int J Cardiol. 2007;120:10–27.

    Article  CAS  PubMed  Google Scholar 

  8. Waal-Manning HJ. Atenolol and three nonselective beta-blockers in hypertension.Pharmacol Ther. 1979;25:8–18.

    CAS  Google Scholar 

  9. Manning HJ, Bolli P. Atenolol versus placebo in mild hypertension: renal metabolic and stress antipressor effects.Br J Clin Pharmacol. 1980;9:553–560.

    Google Scholar 

  10. Warren DJ, Swainson CP, Wright N. Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.Br Med J. 1974;2:193–194.

    Article  CAS  PubMed  Google Scholar 

  11. Snell A, Wallace M. Beta blockade in the presence of renal disease and hypertension.Br Med J. 1974;2:672.

    Article  CAS  PubMed  Google Scholar 

  12. Swainson CP, Winney RJ. Effect of beta-blockade in chronic renal failure.Br Med J. 1976;1:459.

    Article  CAS  PubMed  Google Scholar 

  13. Johns TE, Lopez LM. Bisoprolol: is this just another beta-blocker for hypertension or angina?Ann Pharmacother. 1995;29:403–414.

    CAS  PubMed  Google Scholar 

  14. Czuriga I, Riecansky I, Bodnar J, et al. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).Cardiovasc Drugs Ther. 2003;17:257–263.

    Article  CAS  PubMed  Google Scholar 

  15. ESH/ESC Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.J Hypertens. 2003, 21: 1011–1053.

    Article  Google Scholar 

  16. Schlegel JU, Haway SA. Individual renal plasma flow determination in 2 minutes.J Urol. 1976; 111:282–288.

    Google Scholar 

  17. Gates GE. Glomerular filtration rate: estimation from fractional renal accumulation of 99m-Tc-DTPA.Am J Radiol. 1981;138:565–570.

    Google Scholar 

  18. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of left ventricle by two dimensional echocardiography.J Am Soc Echocardiogr. 1989;2:358–367.

    CAS  PubMed  Google Scholar 

  19. Bakris GL, Hart P, Ritz E. Beta-blockers in the management of chronic kidney disease.Kidney Int. 2006;70:1905–1913.

    CAS  PubMed  Google Scholar 

  20. Ruilope LM, Alcazar JM, Hernandez E, Moreno F, Martinez MA, Rodicio J. Does an adequate control of blood pressure protect the kidney in essential hypertension?J Hypertens. 1990;8:525–531.

    Article  CAS  PubMed  Google Scholar 

  21. Parving HH, Andersen AR, Smith UM, Home L, Mathiesen ES, Svendsen PA. Effect of antihypertensive treatment on kidney function and diabetic nephropathy.BMJ. 1987;294:1443–1447.

    Article  CAS  PubMed  Google Scholar 

  22. Baker JG. The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors.Br J Pharmacol. 2005;144:317–322.

    Article  CAS  PubMed  Google Scholar 

  23. Oral I, Vareka I, Marek D. The effect of a single dose of bisoprolol on changes in blood pressure and hemodynamic indicators in patients with mild hypertension.Vnitr Lek. 1992;38:980–985.

    CAS  PubMed  Google Scholar 

  24. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure.Kidney Int. 1989;35:670–674.

    Article  CAS  PubMed  Google Scholar 

  25. Scaglione R, Ganguzza A, Corrao S, et al. Effect of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.Blood Press. 1995;4:363–368.

    Article  CAS  PubMed  Google Scholar 

  26. Scaglione R, Indovina A, Parrinello G, et al. Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: randomized controlled trial versus hydrochlorothiazide.Cardiovasc Drugs Ther. 1992;6:141–146.

    Article  CAS  PubMed  Google Scholar 

  27. Paterna S, Parrinello G, Scaglione R, et al. Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients.Cardiovasc Drugs Ther. 2000;14:529–532.

    Article  CAS  PubMed  Google Scholar 

  28. Licata G, Scaglione R, Guillet C, et al. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.J Hum Hypertens. 1992;6:140–146.

    Google Scholar 

  29. Licata G, Scaglione R, Ganguzza A, et al. Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients: a randomized controlled study versus placebo.Eur J Clin Pharmacol. 1993;45:307–311.

    Article  CAS  PubMed  Google Scholar 

  30. Uehara Y, Takada S, Hirawa N, et al. Vasoconstrictor and renal protection induced by beta 1-selective adrenoceptor antagonist bisoprolol.J Cardiovasc Pharmacol. 1994;23:897–906.

    Article  CAS  PubMed  Google Scholar 

  31. Gluck Z, Reubi FC. Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.Eur J Clin Pharmacol. 1986;31:107–111.

    Article  CAS  PubMed  Google Scholar 

  32. Leeman M, van de Borne P, Collart F, et al. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.J Cardiovasc Pharmacol. 1993;22:785–791.

    Article  CAS  PubMed  Google Scholar 

  33. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.J Am Soc Nephrol. 1998;9:224–230.

    CAS  PubMed  Google Scholar 

  34. Aunapuu M, Pechter U, Arend A, Suuroja T, Ots M. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.Medicina (Kaunas). 2003;39:975–979.

    Google Scholar 

  35. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms.Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153-R1167.

    CAS  PubMed  Google Scholar 

  36. Kvam FI, Ofstad J, Iversen BM. Effects of antihypertensive drug on autoregulation of RBF and glomerular capillary pressure in SHR.Am J Physiol. 1998;275:F576-F584.

    CAS  PubMed  Google Scholar 

  37. Iversen BM, Sekse I, Ofstad J. Resetting of renal blood flow autoregulation in spontaneously hypertensive rats.Am J Physiol. 1987;252:F480-F486.

    CAS  PubMed  Google Scholar 

  38. Iversen BM, Kvam FI, Matre K, Ofstad J. Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats.Am J Physiol Renal Physiol. 1998;275:576–584.

    Google Scholar 

  39. Willenheimer R, van Veldhuisen DJ, Silke B, et al, CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS III).Circulation. 2005;112:2426–2435.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Care, University of Palermo, Italy

    Salvatore Paterna, Gabriella La Rocca, Roberta Antona, Laura Vernuccio, Ersilia Fornaciari, Antonina Tarantino, Ercole Piccione & Giuseppe Licata

  2. Department of Internal Medicine, University of Palermo, Piazza delle Cliniche 2, Italy

    Gaspare Parrinello & Daniele Torres

  3. Department of Cardiology, GF Ingrassia Hospital, Italy

    Pietro Di Pasquale & Sergio Fasullo

Authors
  1. Salvatore Paterna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gaspare Parrinello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pietro Di Pasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniele Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriella La Rocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberta Antona
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laura Vernuccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ersilia Fornaciari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Antonina Tarantino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ercole Piccione
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sergio Fasullo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Giuseppe Licata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaspare Parrinello.

Additional information

An erratum to this article can be found online at http://dx.doi.org/10.1007/s12325-008-0046-6.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paterna, S., Parrinello, G., Di Pasquale, P. et al. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension. Adv Therapy 24, 1260–1270 (2007). https://doi.org/10.1007/BF02877772

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02877772

Keywords

Search

Navigation